NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Chong Kun Dang Pharmaceutical Corp. Logo
Develops and manufactures drugs for systemic anti-infectives and metabolic diseases.
South Korea
185750
CHOONG ANG VACCINE LABORATORY Logo
Develops and manufactures vaccines, pharmaceuticals, and feed additives for animals.
South Korea
072020
CHOSA Oncology AB Logo
Develops diagnostics and therapeutics for platinum-based chemotherapy.
Sweden
CHOSA
CHUGAI PHARMACEUTICAL CO., LTD. Logo
A research-driven pharmaceutical company developing innovative medical products.
Japan
4519
CHUKYOIYAKUHIN CO.,LTD. Logo
Offers health products and pharmaceuticals via a direct-to-home placement service.
Japan
4558
Cidara Therapeutics, Inc. Logo
Develops targeted immunotherapies and anti-infectives for serious diseases.
United States of America
CDTX
Cinclus Pharma Holding AB Logo
Clinical-stage pharma company developing a PCAB for gastric acid-related diseases.
Sweden
CINPHA
Cingulate Inc. Logo
A clinical-stage biopharma firm developing treatments for ADHD and anxiety.
United States of America
CING
CITIUS ONCOLOGY, INC. Logo
Biopharmaceutical company developing and commercializing targeted oncology therapies.
United States of America
CTOR
Citius Pharmaceuticals, Inc. Logo
A late-stage biopharmaceutical company developing and commercializing critical care products.
United States of America
CTXR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.